🌍 Tomorrow it begins – ILCS 2025! On 26ᵗʰ September in Lausanne & online, experts from 9 countries will present on the latest in biomarkers, targeted therapies, ADCs, IO, and SCLC. A full day of science, debate, and collaboration awaits. Last chance to join – register now ⬇️

Great agenda in prospect addressing some of the key questions in lung cancer. It’s available virtually w free registration so signup now! #lcsm

Did you know that 30% European centres still using RT-PCR, and only 25% routinely using NGS, in diagnosis of NSCLC? Striking, and disappointing, data Great talk from Marius Ilié at ILCS 2025 International Lung Cancer Summit Alfredo Addeo MD Solange Peters Marius.Ilié

Beautiful presentation on EGFR and ALK by Prof Tom John at #ILCS25 really enjoying it with my co-chair Solange Peters

If you have a challenging topic do not hesitate, hand it over to Stephanie Saw . She is delivering a superb talk on her2 and met alterations at #ILCS25

ChemoIO or TKI for MET Ex14 Skipping? Retrospective study But suggests role for chemo IO if OD-L1 >80% Interesting, because MET TKIs often problematic with oedema. So good to have alternative in select patients International Lung Cancer Summit Alfredo Addeo MD Solange Peters

Noemi Reguart now on ADC, present and future #ILCS25. It is getting crowded and we are really hoping to get more effective drugs to offer to our patients.

Dr. Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ discusses #EGFR NSCLC at the International Lung Cancer Summit. Combination therapy should now be considered our standard for first-line therapy with OS advantages seen using osi + chemo (FLAURA2) and amivantamab + lazertinib (MARIPOSA). Learning about impact on acquired resistance.

Who better than Patrick Forde to talk about neoadjuvant and perioperative IO in NSCLC at #ILCS25

Patrick Forde : What predicts relative benefit in neoadjuvant chemoIO? ❌ Histology ❌ Stage ✅ PD-L1 ❓ Smoking history ❌ KRAS / KEAP / STK11 status International Lung Cancer Summit Alfredo Addeo MD

Role of adding IO to chemoRT in stage III NSCLC? Now Dr Filippi at #ILCS25

Happy birthday to Dr. Andrea R. Filippi - speaking today International Lung Cancer Summit on radiation strategies for stage III NSCLC. Will induction chemo-IO help further improve outcomes with chemoradiation + durvalumab? Or can we use pharmacodynamic markers like ctDNA in adaptive risk models?

Many thanks to Alfredo Addeo MD Solange Peters Mehrpouya Mobin for the invite to #ILCS2025, had a wonderful time learning from Prof Tom John Tom Newsom-Davis Xiuning Le MD PhD Noemi Reguart Patrick Forde Rami Manochakian MD, FASCO Cancer Education Marius.Ilié and making 🍕together!

🙏It was an honor to join GREAT friends & global experts to speak about #SmallCell #LungCancer at the: ⭐️2025 #ILCS International Lung Cancer Summit KUDOS to the amazing chairs & organizing committee on a: ✅VERY #Educational & Interactive meeting with participants from more than 100 countries.

An outstanding meeting organized by Mehrpouya Mobin Alfredo Addeo MD & Solange Peters , great discussions and participants from over 100 countries joined online! #lcsm

ILCS25 was a great success – thank you to everyone who joined us onsite in Lausanne and online worldwide! 🌍 All sessions are now available to watch on demand. If you haven’t registered yet, it’s not too late – sign up today and access the full program of insights and debates ⬇️

We are happy to announce that the ETOP Slide deck of 2025 WCLC is now available online: etop.ibcsg.org/research-and-n…

Two big lung abstracts make the Presidential II session at #ESMO25 🫵 Be there #LCSM

2/ Stephen V Liu, MD on a International Lung Cancer Summit talk from Patrick Forde on outcomes with neoadjuvant IO: x.com/StephenVLiu/st…

🚨 Check our Top 10 #LungCancer abstracts for ESMO - Eur. Oncology 2025! We’ve hand-picked the must-see sessions with times, rooms & presenters 🔑 📅 Stay on track in Berlin and simply import these directly to your calendar by clicking this link: 👉 lungsummit.org/wp-content/upl… Which lung